Ownership history in MPM BioImpact LLC · 6 quarters on record
This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Arcutis Biotherapeutics inc (ARQT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 531,200 | +277,063 | +109.0% | 1.77% | $15.4M | $29.04 |
| 2023 Q1 | REDUCED | 254,137 | -7,932 | -3.0% | 0.73% | $2.8M | $11.00 |
| 2022 Q4 | ADDED | 262,069 | +4,884 | +1.9% | 1.01% | $3.9M | $14.80 |
| 2022 Q3 | REDUCED | 257,185 | -1,315 | -0.5% | 1.16% | $4.9M | $19.11 |
| 2022 Q2 | UNCHANGED | 258,500 | — | 0% | 1.53% | $5.5M | $21.31 |
| 2022 Q1 | INITIATED | 258,500 | — | — | 1.34% | $5.0M | $19.26 |
As of 2025 Q4 — sorted by position size